Balasa Dinverno & Foltz LLC Penumbra Inc Transaction History

Balasa Dinverno & Foltz LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$153.32 - $191.72 $2.71 Million - $3.39 Million	-17,707 Closed	0 $0
Q1 2020 Apr 30, 2020	SELL	$124.34 - $193.76 $70,625 - $110,055	-568 Reduced 3.11%	17,707 $2.86 Million
Q2 2019 Aug 07, 2019	SELL	$124.65 - $167.39 $662,390 - $889,510	-5,314 Reduced 22.53%	18,275 $2.92 Million
Q1 2019 May 10, 2019	SELL	$115.84 - $160.31 $250,330 - $346,429	-2,161 Reduced 8.39%	23,589 $3.47 Million
Q3 2018 Oct 24, 2018	SELL	$121.55 - $156.8 $189,131 - $243,980	-1,556 Reduced 5.7%	25,750 $3.86 Million
Q1 2018 Apr 23, 2018	SELL	$84.6 - $126.1 $248,300 - $370,103	-2,935 Reduced 9.71%	27,306 $3.16 Million
Q4 2017 Feb 05, 2018	SELL	$91.55 - $115.85 $97,775 - $123,727	-1,068 Reduced 3.41%	30,241 $2.85 Million
Q3 2017 Oct 18, 2017	BUY	$79.65 - $90.3 $2.49 Million - $2.83 Million	31,309	31,309 $2.83 Million

370

29.1M

220K

158K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.01B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Balasa Dinverno & Foltz LLC, based on Form 13F filings with the SEC.

Stay updated on Balasa Dinverno & Foltz LLC with notifications on news.